BioSpace News Archive

Forte Biosciences, Inc. (NASDAQ: FBRX) ( www.fortebiorx.com ), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte’s Board of Directors approved the grant of an equity award to purchase 80,000 shares of common stock to a new non-execu

Cytovia Therapeutics, an emerging biopharmaceutical company and the New York Stem Cell Foundation (NYSCF) Research institute today announced the filing of a provisional patent application with the U.S. Patent & Trademark Office (USPTO) for the differentiation of Natural Killer (NK) cells from induced pluripotent stem cells (iPSCs). The NYSCF Research Institute is a pioneer and acknowledged leader in stem cell technology, having developed the NYSC

Todos Medical Ltd. (OTCQB: TOMDF) , an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has appointed Marsha Fontanive as Vice President of Sales, and Chris Gross as Vice President of Sales Operations. Collectively,

University of Michigan spinout readies for clinical trials with lead candidate ASX-100, a novel spherical particle that releases a safe and effective anti-inflammatory agent, salicylic acid, directly to over-reactive immune cells

Kannalife, Inc. announced that the Company has been issued patents in Austria, Luxembourg, Liechtenstein, and the Principality of Monaco for its patent known as WO2015/106108A2 titled, “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy”.

The Parkinson’s Foundation today announced expanded virtual programs to support the Parkinson’s disease (PD) community during the ongoing COVID-19 pandemic. Fall Moving Day events, the Foundation’s signature fundraising walk event will take place online in 18 cities across the country. Additionally, the Foundation will offer n

September marks “MDA National Muscular Dystrophy Awareness Month,” an annual observance that raises awareness for more than 250,000 families across the nation who are living with neuromuscular disease

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced it has entered into a scientific research and licensing agreement with Nathaniel R. Landau, PhD and NYU Langone Health through which CARISMA

Sonde Health, a leading vocal biomarker technology platform that detects health symptoms from a few seconds of voice, today announced it has acquired NeuroLex Laboratories, Inc., a leading voice-enabled survey and data acquisition platform.

Otsuka America Pharmaceutical, Inc., (Otsuka) today announces that it has purchased the assets of Proteus Digital Health, Inc. (Proteus), including assets and intellectual property for its ingestible and wearable sensor technology.